- Home
- About
- Warning Signs & Symptoms
- Ovarian Cancer Overview
- Prevention, Early Detection/Screening & Causes
- Genetics
- Types of Ovarian Cancer
- Diagnosis & Staging
- Treatment Overview
- Surgery
- Chemotherapy
- Radiology & Radiation Therapy
- Hormonal (Anti-Estrogen) Therapy
- Biological (Immunotherapy & Vaccine) Therapy
- Gene Therapy
- Alternative & Complementary Therapy
- Clinical Development
- Clinical Trials
- Coping
- Survivorship
- Ovarian Cancer Resources
- Contact
Libby's H*O*P*E*
*Helping*Ovarian Cancer Survivors*Persevere Through*Education
-
"Once you choose hope, anything is possible." -- Christopher Reeve
Ovarian Cancer News – Shared Google Reader- Physicians Are Talking About: Tort Reform: Does Saying "I'm Sorry" Help? November 16, 2009Physicians are often reluctant to apologize for clinical errors because their words can be used in malpractice litigation as admissions of fault. MPC members discuss whether saying "I'm sorry" can help. Medscape Family Medicine
- EntreMed's ENMD-2076 Active in Solid and Hematological Cancers - PR Newswire (press release) November 16, 2009EntreMed's ENMD-2076 Active in Solid and Hematological CancersPR Newswire (press release)The Company also announced that it has selected ovarian cancer as an initial Phase 2 indication. Initial data for the Phase 1 clinical study with ENMD-2076 ...Market Report -- In Play (ENMD)MSN Moneyall 18 news articles »
- Nintendo Wii may provide actual exercise: study November 16, 2009ORLANDO, Florida (Reuters) - The new active Wii video games from Nintendo Co Ltd may be creating a healthier generation of couch potato, according to a new study presented on Monday.
- Heart and Bone Damage from Low Vitamin D Tied to Declines in Sex Hormones-11/15/09 November 16, 2009Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone.
- Predicting the site of origin of tumors by a gene expression signature derived from normal tissues November 16, 2009Predicting the site of origin of tumors by a gene expression signature derived from normal tissues Oncogene advance online publication, November 16, 2009. doi:10.1038/onc.2009.398 Authors: E Staub, H -J Buhr & J Gröne
- New study links vitamin D deficiency to cardiovascular disease and death November 16, 2009(Intermountain Medical Center) Researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City found that patients with very low levels of Vitamin D were 77 percent more likely to die, 45 percent more likely to develop coronary artery disease, and 78 percent were more likely to have a stroke than patients with normal levels. Patients wit […]
- New Findings From Northwestern University Describe Advances In Ovarian Cancer November 14, 2009According to a study from the United States, About half of unaffected BRCA1/2 carriers have a negative family history, confounding efforts toward presymptomatic carrier identification. Ovarian cancer is preventable for known carriers but is otherwise highly lethal.
- Law Seeks to Ban Misuse of Genetic Testing - New York Times November 15, 2009Law Seeks to Ban Misuse of Genetic TestingNew York TimesThese tests identify variations in genes, like whether a woman has a predisposition for ovarian cancer. Such testing can help determine which course of ...and more »
- Gene Linked to Breast Cancer Might Boost Heart Health - U.S. News & World Report November 15, 2009Gene Linked to Breast Cancer Might Boost Heart HealthU.S. News & World ReportMutated forms of the BRCA1 and BRCA2 genes can each raise a woman's odds for breast and ovarian cancer risk at a younger age. When working right, the genes ...and more »
- Quest Stops Killer With Specialized Diagnostic Software - InformationWeek November 15, 2009Quest Stops Killer With Specialized Diagnostic SoftwareInformationWeekPatients likely to have ovarian cancer can then be referred to surgeons who specialize in gynecologic cancers, since they tend to have better outcomes than ...
- Going public with cancer battle, actress Kathy Bates aims to encourage others - Memphis Commercial Appeal November 15, 2009Memphis Commercial AppealGoing public with cancer battle, actress Kathy Bates aims to encourage othersMemphis Commercial Appeal"I was diagnosed with ovarian cancer in August of 2003, and during the years that followed, while I was in treatment, I chose not to go public with it," ...and more »
- What's the evidence for a second round of chemotherapy? - guardian.co.uk November 15, 2009What's the evidence for a second round of chemotherapy?guardian.co.ukThe studies looked at whether women with ovarian cancer who were given a second round of chemotherapy after receiving chemotherapy and surgery lived longer ...A second round of chemotherapyguardian.co.ukall 2 news articles »
- Helping your patients to deal with a predisposition to genetic disease - Journal of the American Academy of Physician Assistants November 15, 2009Helping your patients to deal with a predisposition to genetic diseaseJournal of the American Academy of Physician Assistants... if she should have more children sooner than planned so she can have her ovaries removed by age 35 or 40 years to reduce her risk of ovarian cancer. ...
- Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue November 12, 2009Abstract Vascular endothelial growth factor C (VEGF-C) is a well described chemotactic and growth factor for lymphatic endothelial cells. Its inhibition leads to suppression of lymphatic and distant metastases in mouse models. In ovarian cancer, the relationship between VEGF-C expression and tumor behavior has not yet been determined by a quantitative metho […]
- Leukemia drug fights ovarian cancer - PRESS TV November 14, 2009PRESS TVLeukemia drug fights ovarian cancerPRESS TVA drug commonly used to treat a certain form of leukemia has shown promising results in fighting ovarian cancer, the deadliest malignancy in the female ...
- ESAs Increase Risk for Venous Thromboembolism But Do Not Reduce Blood Transfusions November 10, 2009The new findings come from a study of erythropoiesis-stimulating agents used in cancer patients treated with chemotherapy in community practices. Medscape Medical News
- Casopitant Helps Curb Chemotherapy Emesis November 13, 2009Casopitant in combination with ondansetron and dexamethasone can help prevent chemotherapy-induced nausea and vomiting. Reuters Health Information
- Erythropoietin, Darbepoetin Increase VTE Risk in Elderly Cancer Patients - OncologySTAT November 13, 2009Elderly cancer patients who take erythropoiesis-stimulating agents while undergoing chemotherapy are at increased risk of venous thromboembolism, according to a large epidemiologic study published online Nov. 11 in the Journal of the National Cancer Institute.
- Get Your Swine Flu Shot Right Here | The Daily Scan | GenomeWeb November 13, 2009It's time to step up that research into the H1N1 virus. The Centers for Disease Control and Prevention announced that "an estimated 22 million Americans have been sickened with swine flu since April and 3,900 have died," according to this article in the Wall Street Journal. "The sharply higher numbers of illnesses and deaths are the resul […]
- Risk of gynecological cancers in users of estradio... [Climacteric. 2009] - PubMed result November 13, 2009Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Switzerland.OBJECTIVES: Use of postmenopausal hormone replacement therapy (HRT) has been associated with an elevated risk of gynecological cancers. There is evidence that the effect differs with the type of hormone used. Dydrogesterone is pharmacolog […]
- Physicians Are Talking About: Tort Reform: Does Saying "I'm Sorry" Help? November 16, 2009
-
- Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, (ii) receive Libby's H*O*P*E* (tm) updates via email; or (iii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.
- New Ovarian Cancer Clinical Trials (Past 14 Days)
- Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin November 10, 2009
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer November 11, 2009
- Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor November 6, 2009
-
Recent Comments
Blogroll
-
-
-
-
-
-
-
-
